Wanling Wu

45 papers receiving 708 citations

Peers

Wanling Wu
Comparison fields: 5 of 103
  • Rehabilitation 60
  • Biochemistry 36
  • Endocrinology, Diabetes and Metabolism 100
  • Complementary and alternative medicine 49
  • Pharmacology 52
Replace Wanli Xue with:
Wanli Xue China
Kejia Wang China
Xiaoyu Liu China
Mehryar Zargari Iran
Huiying Fu China
Ningning Wang China
Xueqing Hu China
Rohinton S. Tarapore United States
Paola Romecín Spain
Kaiyue Wang China
Wanling Wu relative to Wanli Xue China Wanli Xue's profile →
Citations per field
00.5×2.9×
Wanli Xue · 1×
Citations per year

Countries citing papers authored by Wanling Wu

Since Specialization
Citations

This map shows the geographic impact of Wanling Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanling Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanling Wu more than expected).

Fields of papers citing papers by Wanling Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanling Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanling Wu. The network helps show where Wanling Wu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Wanling Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wanling Wu Line = papers co-authored together Wanling Wu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20251
4 20250
5 20250
6 20241
7 20231
8 202220
9 201619
10 201435
11 201425
12 201313
13 20123
14 20111
15 20112
16 20111
17 200933
18
Correlation of polymorphism of angiotensin converting enzyme gene and cigarette smoking with ischemic stroke
20081
19 200228
20 20022

About Wanling Wu

Wanling Wu is a scholar working on Complementary and alternative medicine, Hematology, Cancer Research, Pharmacology and Endocrinology, Diabetes and Metabolism, having authored 48 papers that have together received 726 indexed citations. Recurring topics across this work include Traditional Chinese Medicine Analysis (6 papers), Sexual Differentiation and Disorders (6 papers), Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers), Hormonal and reproductive studies (4 papers), Hormonal Regulation and Hypertension (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Circular RNAs in diseases (4 papers). The work is most often cited by research in Rehabilitation (60 citations), Biochemistry (36 citations), Endocrinology, Diabetes and Metabolism (100 citations), Complementary and alternative medicine (49 citations) and Pharmacology (52 citations). Wanling Wu has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Dongye Li, Xiaoqin Wang, Tongda Xu, Dehua Jiang, Defeng Pan, Nianyi Li, Qin‐Fen Chen, Mengxue Zhang, Weiyang Liu and Hong Zhu. Their work appears in journals such as Brain and Behavior, PLoS ONE, Scientific Reports, JAMA Network Open and The International Journal of Biochemistry & Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026